prikaz prve stranice dokumenta Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
  Preuzmi
PDF 2.01 MB
Znanstveni rad - Pregledni rad
Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine, 11 (2022), 7; 1793. https://doi.org/10.3390/jcm11071793
Murthy, Vignesh; Mylonas, Petros; Carey, Barbara; Yogarajah, Sangeetha; Farnell, Damian; Addison, Owen; Cook, Richard; Escudier, Michael; Diniz-Freitas, Marcio; Limeres, Jacobo; Monteiro, Luis; Silva, Luis; Fricain, Jean-Cristophe; Catros, Sylvain; Fenelon, Mathilde; Lodi, Giovanni; Lombardi, Niccolò; Brailo, Vlaho; Ariyaratnam, Raj; López-López, José; Albuquerque, Rui Više autora...

Citirajte ovaj rad

Murthy, V., Mylonas, P., Carey, B., Yogarajah, S., Farnell, D., Addison, O. ... Albuquerque, R. (2022). Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11. (7). doi: 10.3390/jcm11071793

Murthy, Vignesh, et al. "Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine, vol. 11, br. 7, 2022. https://doi.org/10.3390/jcm11071793

Murthy, Vignesh, Petros Mylonas, Barbara Carey, Sangeetha Yogarajah, Damian Farnell, Owen Addison, Richard Cook, et al. "Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine 11, br. 7 (2022). https://doi.org/10.3390/jcm11071793

Murthy, V., et al. (2022) 'Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis', Journal of Clinical Medicine, 11(7). doi: 10.3390/jcm11071793

Murthy V, Mylonas P, Carey B, Yogarajah S, Farnell D, Addison O, i sur.. Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine [Internet]. 24.03.2022. [pristupljeno 20.04.2024.];11(7). doi: 10.3390/jcm11071793

V. Murthy, et al., "Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis", Journal of Clinical Medicine, vol. 11, br. 7, Ožujak 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:127:104311. [Citirano: 20.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:127:104311
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis
AutorVignesh Murthy
AutorPetros Mylonas
AutorBarbara Carey
AutorSangeetha Yogarajah
AutorDamian Farnell
AutorOwen Addison
AutorRichard Cook
AutorMichael Escudier
AutorMarcio Diniz-Freitas
AutorJacobo Limeres
AutorLuis Monteiro
AutorLuis Silva
AutorJean-Cristophe Fricain
AutorSylvain Catros
AutorMathilde Fenelon
AutorGiovanni Lodi
AutorNiccolò Lombardi
AutorVlaho Brailo
AutorRaj Ariyaratnam
AutorJosé López-López
AutorRui Albuquerque
Autorova ustanovaSveučilište u Zagrebu
Stomatološki fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Dentalna medicina
Oralna medicina
Sažetak (engleski)
Oral submucous fibrosis (OSF) is a chronic progressive condition affecting the oral cavity, oropharynx and upper third of the oesophagus. It is a potentially malignant disorder. The authors collated and analysed the existing literature to establish the overall malignant transformation rate (MTR). A retrospective analysis of medical and dental scientific literature using online indexed databases was conducted for the period 1956 to 2021. The quality of the enrolled studies was assessed by the Newcastle-Ottawa Scale (NOS). A meta-analysis using a random effects model of a single proportion was performed along with statistical tests for heterogeneity. The overall proportion of malignancy across all studies was 0.06 (95% CI, 0.02–0.10), indicating an overall 6% risk of malignant transformation across all studies and cohorts. Sub-group analyses revealed strong differences in proportion of malignancy according to ethnicity/cohort; Chinese = 0.02 (95% CI 0.01–0.02), Taiwanese = 0.06 (95% CI, 0.03–0.10), Indian = 0.08 (95% CI, 0.03–0.14) and Pakistani = 0.27 (95% CI 0.25–0.29). Overall, the MTR was 6%; however, wide heterogeneity of the included studies was noted. Geographic variations in MTR were noted but were not statistically significant. Further studies are required to analyse the difference between cohort groups.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of Clinical Medicine
Brojčani podacivol. 11, br. 7, 1793
e-ISSN2077-0383
DOIhttps://doi.org/10.3390/jcm11071793
URN:NBNurn:nbn:hr:127:104311
Datum objave publikacije2022-03-24
URL dokumentahttps://www.mdpi.com/2077-0383/11/7/1793
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2022-11-02 07:59:03